Printer Friendly

'APPROVABLE' LETTER RECEIVED BY SEARLE/LOREX FOR AMBIEN

 'APPROVABLE' LETTER RECEIVED BY SEARLE/LOREX FOR AMBIEN
 CHICAGO, April 24 /PRNewswire/ -- Searle today announced that Lorex Pharmaceuticals, its joint venture company with French pharmaceutical company Synthelabo, has received an "approvable" letter from the Food and Drug Administration for Ambien(TM) (zolpidem tartrate), a sleep medication. An approvable letter means that final labeling discussions will begin.
 Searle is a research-based pharmaceutical company that develops, manufacturers and markets prescription pharmaceuticals worldwide. It is a wholly owned subsidiary of Monsanto Co. (NYSE: MTC).
 -0- 4/24/92
 /CONTACT: Laura Leber, 708-470-6280, or Jack Domeischel, 708-470-6720, for Searle/
 (MTC) CO: Searle; Lorex Pharmaceuticals ST: Illinois IN: MTC SU:


SH -- NY074 -- 2572 04/24/92 14:49 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 24, 1992
Words:114
Previous Article:CASUAL CLOTHES GAINING GROUND IN THE OFFICE
Next Article:DEPRENYL RESEARCH NOTES NO CHANGE IN COMPANY TO ACCOUNT FOR CURRENT PRESSURES ON SHARE PRICE


Related Articles
FIRST IN A NEW CLASS OF PRESCRIPTION SLEEP AIDS APPROVED FOR MARKETING
ROBERTS PHARMACEUTICAL CORPORATION ACQUIRES FOUR PRESCRIPTION PRODUCTS FROM SEARLE CANADA INC.
EXECUTIVE APPOINTMENTS ANNOUNCED AT SEARLE
APPROVABLE LETTER RECEIVED FOR COVERA-HS(TM)
De Schutter to Retire from Pharmacia Corporation.
SEARLE OPPOSES ITS USE FOR ABORTION Searle Company Warns Of "Serious Adverse Events" With Off-Label Use of Cytotec.
FDA Issues Approvable Letter for AMBIEN CR(TM) (Zolpidem Tartrate Extended Release) CIV for the Treatment of Insomnia.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters